Laurus Labs

Laurus Labs ROE

The Return on Equity (ROE) of Laurus Labs (LAURUSLABS.NS) as of Oct 15, 2026 is 16.77 %. In the previous year, Return on Equity (ROE) was 8.01 % — a change of 109.32% (higher).

ROE

16.77 %

YoY

109.32%

Last updated:

In 2026, Laurus Labs's return on equity (ROE) was 16.77 %, a 109.32% increase from the 8.01 % ROE in the previous year.

The Laurus Labs ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
6.02 INR
Jan 1, 2020
14.42 INR
Jan 1, 2021
37.87 INR
Jan 1, 2022
24.69 INR
Jan 1, 2023
19.57 INR
Jan 1, 2024
3.91 INR
Jan 1, 2025
8.01 INR
Jan 1, 2026
16.77 INR
The Laurus Labs ROE history
YEARROEYoY
16.77 %+109.32%
8.01 %+105.14%
3.91 %-80.04%
19.57 %-20.75%
24.69 %-34.79%
37.87 %+162.52%
14.42 %+139.73%
6.02 %-46.78%
11.30 %-20.95%
14.30 %-8.91%
15.70 %+65.54%
9.48 %-50.28%
19.08 %—
Access this data via the Eulerpool API
Get Free API Key

Laurus Labs Stock analysis

What does Laurus Labs do? Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Since its establishment in 2005, the company has become one of the leading providers of API products on the global market. Answer: Laurus Labs Ltd is an Indian pharmaceutical company specializing in the production of active pharmaceutical ingredients for generics and innovative drugs. Laurus Labs is one of the most popular companies on Eulerpool.

ROE Details

Decoding Laurus Labs's Return on Equity (ROE)

Laurus Labs's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Laurus Labs's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Laurus Labs's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Laurus Labs’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Laurus Labs stock

Return on Equity (ROE) of Laurus Labs is 16.77 % in 2026.

Return on Equity (ROE) of Laurus Labs changed from 8.01 % to 16.77 %, representing a 109.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Laurus Labs since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Laurus Labs with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Laurus Labs

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Laurus Labs